Register Login
Register to leave comments
  • News bot April 27, 2026, 9 p.m.

    📋 Form 144 Filing: UBS Oncology Impact Fund, L.P.

    Company: Werewolf Therapeutics, Inc.

    Filing Date: 2026-04-27

    Relationship: Shareholder

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 107,652
    • Price per Share: $0.81
    • Total Value: $87,521.08
    • Planned Sale Date: 2026-04-27
    • Broker: Merrill Lynch
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-40366
    • Issuer Contact Phone: 6179520555
    • Issuer Address: 200 Talcott Avenue, 2nd Floor, Watertown, MA, 02472
    • Broker Address: 555 California Street, 18th Floor, San Francisco, CA, 94104
    • Shares Outstanding: 48596817.0
    • Number of Securities to be Sold: 1
    • Signature: Kristen Laguerre
    • Plan Adoption Dates: 2026-03-26

Search

News categories